查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629310

生物可吸收血管支架市场，按类型、材料类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Bioresorbable Vascular Scaffold Market, By Type, By Material Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，生物可吸收血管支架市场规模为3.985亿美元，2024年至2032年复合年增长率为8.90%。

生物可吸收血管支架市场-市场动态

心血管疾病的盛行率不断上升推动了对先进治疗方法的需求。

心血管疾病（CVD）盛行率的增加是生物可吸收血管支架（BVS）市场的关键驱动力。随着全球 CVD 负担的增加，越来越需要 BVS 等先进治疗方法来支持冠状动脉健康。据世界卫生组织 (WHO) 称，CVD 是全球主要死亡原因，估计每年导致 1,790 万人死亡，占全球死亡人数的 32%。在美国，疾病管制与预防中心 (CDC) 报告称，近 1,820 万名 20 岁及以上的成年人患有冠状动脉疾病，这凸显了对 BVS 等创新解决方案的需求。随着CVD发病率持续上升，对生物可吸收支架等有效、微创治疗的需求预计将成长，进而推动市场向前发展。

生物可吸收血管支架市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 8.90% 左右的复合年增长率成长

根据类型细分，预计药物洗脱生物可吸收血管支架将在 2023 年显示最大的市场份额

根据材料类型细分，聚乳酸 (PLA) 是 2023 年的领先细分市场

从应用细分来看，冠心病治疗是2023年的领先细分领域

按地区划分，北美是 2023 年的主要收入来源

生物可吸收血管支架市场-細項分析：

全球生物可吸收血管支架市场根据类型、材料类型、应用、最终用户和地区进行细分。

市场依类型分为三类：药物洗脱生物可吸收血管支架、非药物洗脱生物可吸收血管支架。药物洗脱生物可吸收血管支架部分是生物可吸收血管支架（BVS）市场中最突出的部分。这些支架涂有药物，可透过抑制细胞生长来帮助预防再狭窄（动脉重新狭窄），从而非常有效地确保长期治疗结果。药物洗脱功能的增加显着降低了併发症的风险，这使得这些支架在医疗保健提供者和患者中更受欢迎。随着冠状动脉疾病的治疗越来越注重减少再狭窄和改善临床结果，药物洗脱 BVS 越来越受到青睐。此外，这些支架结合了生物吸附和药物传递的优点，提供了卓越的治疗功效。正在进行的临床研究以及北美和欧洲等地区各种药物洗脱 BVS 产品的成功批准进一步支持了该细分市场的成长。因此，药物洗脱部分预计将在市场上保持主导地位。

市场依材料类型分为两类：聚乳酸（PLA）、聚-L-乳酸（PLLA）、镁基等。聚乳酸 (PLA) 领域在生物可吸收血管支架 (BVS) 市场中最为突出。 PLA因其生物相容性、生物可降解性和机械性能而被广泛应用，使其成为血管支架的理想材料。它提供了在癒合过程中支撑动脉所需的必要强度和灵活性，同时也逐渐被体内吸收，减少了与永久性支架相关的长期併发症。 PLA 在医疗应用（包括其在各种药物输送系统中的使用）方面的良好记录，有助于其在 BVS 市场中占据重要地位。此细分市场的成长是由对微创解决方案的需求不断增长以及基于 PLA 的支架技术在临床试验中的进步所推动的。鑑于其经过验证的有效性和有利的特性，PLA 预计将保持其在市场上的主导地位。

生物可吸收血管支架市场-地理洞察

受心血管疾病高发病率和先进医疗基础设施的推动，北美是生物可吸收血管支架（BVS）市场的领先地区。美国拥有最大的市场份额，这得益于雅培实验室、美敦力和波士顿科学等领先医疗器材公司的强大支持，这些公司正在积极开发和推广生物可吸收支架。该地区受益于有利的监管环境，包括 FDA 对生物可吸收设备的批准，以及强有力的医疗报销政策。加拿大也对这一成长做出了贡献，越来越重视创新的心血管治疗。此外，美国和加拿大医疗保健提供者的广泛研究、临床试验和早期采用新技术进一步推动了市场扩张。对微创手术的需求不断增长以及先进支架技术的采用预计将保持北美在 BVS 市场的主导地位。

生物可吸收血管支架市场-竞争格局：

生物可吸收血管支架（BVS）市场的竞争格局由雅培实验室、波士顿科学公司、美敦力和百多力等主要参与者主导。 Abbott 因其 Absorb BVS 受到认可，专注于高性能支架和广泛的临床试验。波士顿科学公司正在推动生物可吸收支架技术，强调改善临床结果。美敦力 (Medtronic) 不断创新包括 BVS 在内的一系列心血管解决方案，而百多力 (Biotronik) 则专注于血管干预并投资临床研究以提高设备的安全性和有效性。这些公司正在透过创新、扩大临床证据和获得监管批准来竞争引领市场。

最新进展：

2024 年 4 月，FDA 批准雅培的 Esprit BTK，一种依维莫司洗脱生物可吸收支架，用于治疗膝下 (BTK) 腘窝疾病患者。此次批准标誌着 FDA 授权的首个专门用于 BTK 病变的设备。该决定是基于 LIFE-BTK 研究的积极结果，该研究显示与传统血管成形术相比，截肢、血管闭塞、血管重建和再狭窄的风险降低。

目录

第一章：生物可吸收血管支架市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 生物可吸收血管支架市场片段（按类型）
    • 按材料类型分類的生物可吸收血管支架市场片段
    • 生物可吸收血管支架市场片段（依应用）
    • 最终用户的生物可吸收血管支架市场片段
    • 按国家/地区分類的生物可吸收血管支架市场片段
    • 按地区分類的生物可吸收血管支架市场片段
  • 竞争洞察

第 3 章：生物可吸收血管支架主要市场趋势

  • 生物可吸收血管支架市场驱动因素
    • 市场驱动因素的影响分析
  • 生物可吸收血管支架市场限制
    • 市场限制影响分析
  • 生物可吸收血管支架的市场机会
  • 生物可吸收血管支架市场未来趋势

第 4 章：生物可吸收血管支架产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：生物可吸收血管支架市场：地缘政治张力升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：生物可吸收血管支架市场格局

  • 2023 年生物可吸收血管支架市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：生物可吸收血管支架市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 药物洗脱生物可吸收血管支架
    • 非药物洗脱生物可吸收血管支架

第 8 章：生物可吸收血管支架市场 - 依材料类型

  • 概述
    • 按材料类型分類的细分市场份额分析
    • 聚乳酸 (PLA)
    • 聚左旋乳酸 (PLLA)
    • 镁基
    • 其他的

第 9 章：生物可吸收血管支架市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 冠状动脉疾病治疗
    • 週边动脉疾病治疗
    • 其他的

第 10 章：生物可吸收血管支架市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 门诊手术中心
    • 心导管实验室
    • 其他的

第 11 章：生物可吸收血管支架市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物可吸收血管支架主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按材料类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物可吸收血管支架主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按材料类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物可吸收血管支架主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模和预测（按材料类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物可吸收血管支架主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按材料类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲生物可吸收血管支架主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按材料类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析-生物可吸收血管支架产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik
    • Terumo Corporation
    • Stratmotive Technologies (SMT)
    • Reva Medical
    • Koninklijke Philips
    • MIV Therapeutics
    • Stentys
    • Biocube
    • Bioabsorbable Vascular Scaffold Solutions (BVSS)
    • Vascular Concepts
    • Elixir Medical
    • KalliTech
    • Endologix
    • Camtech

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4459

REPORT HIGHLIGHT

The Bioresorbable Vascular Scaffold Market size was valued at USD 398.50 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The bioresorbable vascular scaffold market focuses on devices designed to treat coronary artery disease by temporarily supporting blood vessels and gradually dissolving over time. These scaffolds, made from biocompatible materials, provide a solution to traditional stents by eventually being absorbed by the body. The growing prevalence of cardiovascular diseases and the demand for less invasive, more efficient treatments are driving the market. Technological advancements in scaffold materials and minimally invasive procedures further contribute to its growth. Despite this, challenges such as high costs and concerns about long-term clinical outcomes compared to traditional metallic stents are hindering widespread adoption. The North American and European markets are dominant, while Asia Pacific is experiencing rapid growth due to better healthcare access and rising awareness.

Bioresorbable Vascular Scaffold Market- Market Dynamics

The increasing prevalence of cardiovascular diseases drives demand for advanced treatments.

The increasing prevalence of cardiovascular diseases (CVD) is a key driver for the bioresorbable vascular scaffold (BVS) market. As the global burden of CVD rises, there is a greater need for advanced treatments like BVS to support coronary artery health. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, responsible for an estimated 17.9 million deaths annually, which accounts for 32% of all global deaths. In the United States, the Centers for Disease Control and Prevention (CDC) reports that nearly 18.2 million adults aged 20 and older have coronary artery disease, highlighting the need for innovative solutions such as BVS. As the incidence of CVD continues to rise, the demand for effective, minimally invasive treatments like bioresorbable scaffolds is expected to grow, driving the market forward.

Bioresorbable Vascular Scaffold Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Type segmentation, drug-eluting bioresorbable vascular scaffold was predicted to show maximum market share in the year 2023

Based on Material Type segmentation, Polylactic Acid (PLA) was the leading segment in 2023

Based on Application segmentation, Coronary Artery Disease Treatment was the leading segment in 2023

based on region, North America was the leading revenue generator in 2023

Bioresorbable Vascular Scaffold Market- Segmentation Analysis:

The Global Bioresorbable Vascular Scaffold Market is segmented based on Type, Material Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Drug-eluting bioresorbable vascular scaffold, non-drug-eluting bioresorbable vascular scaffold. The drug-eluting bioresorbable vascular scaffold segment is the most prominent in the bioresorbable vascular scaffold (BVS) market. These scaffolds are coated with medications that help prevent restenosis (re-narrowing of the artery) by inhibiting cell growth, making them highly effective in ensuring long-term treatment outcomes. The addition of drug-eluting capabilities significantly reduces the risk of complications, which has made these scaffolds more popular among healthcare providers and patients. As coronary artery disease treatments increasingly focus on minimizing restenosis and improving clinical results, drug-eluting BVSs are gaining preference. Moreover, these scaffolds combine the benefits of both biosorption and drug delivery, providing superior therapeutic efficacy. This segment's growth is further supported by ongoing clinical studies and the successful approval of various drug-eluting BVS products in regions like North America and Europe. Consequently, the drug-eluting segment is expected to remain dominant in the market.

The market is divided into two categories based on Material Type: Polylactic Acid (PLA), Poly-L-lactic Acid (PLLA), Magnesium-Based, and Others. The Polylactic Acid (PLA) segment is the most prominent in the bioresorbable vascular scaffold (BVS) market. PLA is widely used due to its biocompatibility, biodegradability, and mechanical properties that make it an ideal material for vascular scaffolds. It offers the necessary strength and flexibility required to support the artery during the healing process, while also gradually resorbing into the body, reducing long-term complications associated with permanent stents. PLA's established track record in medical applications, including its use in various drug delivery systems, contributes to its significant presence in the BVS market. The segment's growth is driven by the increasing demand for minimally invasive solutions and the advancement of PLA-based scaffold technologies in clinical trials. Given its proven effectiveness and favorable properties, PLA is expected to maintain its dominance in the market.

Bioresorbable Vascular Scaffold Market- Geographical Insights

North America is the leading region in the bioresorbable vascular scaffold (BVS) market, driven by the high incidence of cardiovascular diseases and advanced healthcare infrastructure. The United States holds the largest market share, supported by a strong presence of leading medical device companies such as Abbott Laboratories, Medtronic, and Boston Scientific, which are actively developing and promoting bioresorbable scaffolds. The region benefits from favorable regulatory environments, including the FDA's approval of bioresorbable devices, along with strong healthcare reimbursement policies. Canada also contributes to the growth, with a growing emphasis on innovative cardiovascular treatments. Additionally, extensive research, clinical trials, and early adoption of new technologies by healthcare providers in the U.S. and Canada further fuel market expansion. The increasing demand for minimally invasive procedures and the adoption of advanced stent technologies are expected to maintain North America's dominance in the BVS market.

Bioresorbable Vascular Scaffold Market- Competitive Landscape:

The competitive landscape of the bioresorbable vascular scaffold (BVS) market is dominated by key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic, and Biotronik. Abbott is recognized for its Absorb BVS, focusing on high-performance scaffolds and extensive clinical trials. Boston Scientific is advancing bioresorbable scaffold technology, emphasizing improved clinical outcomes. Medtronic continues to innovate with a range of cardiovascular solutions, including BVS, while Biotronik specializes in vascular interventions and invests in clinical studies to enhance device safety and effectiveness. These companies are competing to lead the market by innovating, expanding clinical evidence, and securing regulatory approvals.

Recent Developments:

In April 2024, the FDA approved Abbott's Esprit BTK, an everolimus-eluting bioresorbable scaffold, for the treatment of patients with below-the-knee (BTK) infra popliteal disease. This approval marks the first-ever device authorized by the FDA specifically for BTK lesions. The decision was based on the positive results from the LIFE-BTK study, which showed reduced risks of amputation, vessel occlusion, revascularization, and restenosis compared to conventional angioplasty.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic
  • Biotronik
  • Terumo Corporation
  • Stratmotive Technologies (SMT)
  • Reva Medical
  • Koninklijke Philips
  • MIV Therapeutics
  • Stentys
  • Biocube
  • Bioabsorbable Vascular Scaffold Solutions (BVSS)
  • Vascular Concepts
  • Elixir Medical
  • KalliTech
  • Endologix
  • Camtech

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug-eluting bioresorbable Vascular Scaffold
  • Non-Drug-Eluting Bioresorbable Vascular Scaffold

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polylactic Acid (PLA)
  • Poly-L-lactic Acid (PLLA)
  • Magnesium-Based
  • Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Coronary Artery Disease Treatment
  • Peripheral Artery Disease Treatment
  • Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Others

GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bioresorbable Vascular Scaffold Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bioresorbable Vascular Scaffold Market Snippet by Type
    • 2.1.2. Bioresorbable Vascular Scaffold Market Snippet by Material Type
    • 2.1.3. Bioresorbable Vascular Scaffold Market Snippet by Application
    • 2.1.4. Bioresorbable Vascular Scaffold Market Snippet by End-User
    • 2.1.5. Bioresorbable Vascular Scaffold Market Snippet by Country
    • 2.1.6. Bioresorbable Vascular Scaffold Market Snippet by Region
  • 2.2. Competitive Insights

3. Bioresorbable Vascular Scaffold Key Market Trends

  • 3.1. Bioresorbable Vascular Scaffold Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bioresorbable Vascular Scaffold Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bioresorbable Vascular Scaffold Market Opportunities
  • 3.4. Bioresorbable Vascular Scaffold Market Future Trends

4. Bioresorbable Vascular Scaffold Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bioresorbable Vascular Scaffold Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bioresorbable Vascular Scaffold Market Landscape

  • 6.1. Bioresorbable Vascular Scaffold Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bioresorbable Vascular Scaffold Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Drug-eluting bioresorbable Vascular Scaffold
    • 7.1.3. Non-Drug-Eluting Bioresorbable Vascular Scaffold

8. Bioresorbable Vascular Scaffold Market - By Material Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Material Type, 2023 & 2032 (%)
    • 8.1.2. Polylactic Acid (PLA)
    • 8.1.3. Poly-L-lactic Acid (PLLA)
    • 8.1.4. Magnesium-Based
    • 8.1.5. Others

9. Bioresorbable Vascular Scaffold Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Coronary Artery Disease Treatment
    • 9.1.3. Peripheral Artery Disease Treatment
    • 9.1.4. Others

10. Bioresorbable Vascular Scaffold Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Cardiac Catheterization Laboratories
    • 10.1.5. Others

11. Bioresorbable Vascular Scaffold Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Bioresorbable Vascular Scaffold Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Bioresorbable Vascular Scaffold Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Bioresorbable Vascular Scaffold Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Bioresorbable Vascular Scaffold Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Bioresorbable Vascular Scaffold Key Manufacturers in the Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Bioresorbable Vascular Scaffold Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Boston Scientific Corporation
    • 12.2.3. Medtronic
    • 12.2.4. Biotronik
    • 12.2.5. Terumo Corporation
    • 12.2.6. Stratmotive Technologies (SMT)
    • 12.2.7. Reva Medical
    • 12.2.8. Koninklijke Philips
    • 12.2.9. MIV Therapeutics
    • 12.2.10. Stentys
    • 12.2.11. Biocube
    • 12.2.12. Bioabsorbable Vascular Scaffold Solutions (BVSS)
    • 12.2.13. Vascular Concepts
    • 12.2.14. Elixir Medical
    • 12.2.15. KalliTech
    • 12.2.16. Endologix
    • 12.2.17. Camtech

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us